effect of membrane-bound complement regulatory proteins on colorectal carcinoma. Eur. J. Immunol. 32, 128-135.
Gelderman, K.A., Tomlinson, S., Ross, G.D., and Gorter, A. (2004). Complement function in mAb-mediated cancer immunotherapy. Trends Immunol. 25, 158-164.
Gćnin, P., Lin, R., Hiscott, J., and Civas, A. (2012). Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression. PLoS ONE 7, e38336.
Geoerger, B., Grill, J., Opolon, P., Morizet, J., Aubert, G., Terrier-Lacombe, M.-J., Bressac de-Paillerets, B., Barrois, M., Feunteun, J., Kim, D.H., and Vassal, G. (2002). Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 Status in human malignant glioma xenografts. Cancer Res. 62, 764-772.
Georgel, P., Jiang, Z., Kunz, S., Janssen, E., Mols, J., Hoebe, K., Bahram, S., Oldstone, M.B.A., and Beutler, B. (2007). Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362, 304-313.
Gionanlis, L., Alexopoulos, E., Papagianni, A., Leontsini, M, and Memmos, D. (2008). Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: The role of TGF-pl and C5b-9. Ren. Fail. 30, 239-246.
Glodowski, D.R., Petersen, J.M., and Dahlberg, J.E. (2002). Complex nuclear localization signals in the matrix protein of Vesicular Stomatitis Virus. J. Biol. Chem. 277, 46864-46870.
Gongora, C., and Mechti, N. (1999). L’interferon : un mecanisme complexe de signalisation. Buli. Cancer (Paris) 86, 911-919.
Goswami, S., Sahai, E., Wyckoff, J.B., Cammer, M., Cox, D., Pixley, F.J., Stanley, E.R., Segall, J.E., and Condeelis, J.S. (2005). Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-l/epidermal growth factor paracrine loop. Cancer Res. 65, 5278-5283.
Gowda, D.C., Petrella, E.C., Raj, T.T., Bredehorst, R., and Vogel, C.W. (1994). Immunoreactivity and function of oligosaccharides in cobra venom factor. The Journal of Immunology 152, 2977-2986.
Greentree, L. (1983). Hodgkin's disease: therapeutic role of measles vaccine. American joumal of medecine 75.
194